Dodecafluoropentane emulsion as an oxygen therapeutic.

Dodecafluoropentane blood substitute fluorocarbon oxygen delivery oxygen therapeutic perfluorocarbon

Journal

Artificial cells, nanomedicine, and biotechnology
ISSN: 2169-141X
Titre abrégé: Artif Cells Nanomed Biotechnol
Pays: England
ID NLM: 101594777

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 23 9 2024
pubmed: 23 9 2024
entrez: 23 9 2024
Statut: ppublish

Résumé

Dodecafluoropentane emulsion (DDFPe) is a fluorocarbon (FC) under clinical development as an oxygen therapeutic and is regulated as a blood substitute. Compared to all the prior FCs studied, DDFP is the most advantageous for oxygen delivery and it is active at a lower concentration (1/200th to 1/1000th the weight of other FCs). DDFP has a boiling point of 29 °C, is more water soluble than prior FCs, and following IV administration clears

Identifiants

pubmed: 39308047
doi: 10.1080/21691401.2024.2402908
doi:

Substances chimiques

Fluorocarbons 0
Emulsions 0
perfluoropentane 678-26-2
Oxygen S88TT14065
Blood Substitutes 0
Pentanes 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

462-475

Auteurs

Evan Unger (E)

NuvOx Pharma, Tucson, AZ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH